Fifteen-Year Immunologic Follow-Up of Women Who Received One, Two and Three Doses of the Bivalent HPV Vaccine in the Costa Rica HPV-16/18 Vaccine Trial (CVT) the CVT EXTEND Study

Conditions:   Human Papillomavirus;   Cervical Cancer Intervention:   Sponsor:   National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials